Deerfield Management Company, L.p. (series C) - Net Worth and Insider Trading
Deerfield Management Company, L.p. (series C) Net Worth
The estimated net worth of Deerfield Management Company, L.p. (series C) is at least $55 Million dollars as of 2024-04-27. Deerfield Management Company, L.p. (series C) is the of DA32 Life Science Tech Acquisition Corp and owns about 3,850,000 shares of DA32 Life Science Tech Acquisition Corp (DALS) stock worth over $40 Million. Deerfield Management Company, L.p. (series C) is also the of eHealth Inc and owns about 3,264,588 shares of eHealth Inc (EHTH) stock worth over $15 Million. Details can be seen in Deerfield Management Company, L.p. (series C)'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Deerfield Management Company, L.p. (series C) has not made any transactions after 2021-07-30 and currently still holds the listed stock(s).
Transaction Summary of Deerfield Management Company, L.p. (series C)
Deerfield Management Company, L.p. (series C) Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deerfield Management Company, L.p. (series C) owns 85 companies in total, including Oncorus Inc (ONCR) , Larimar Therapeutics Inc (LRMR) , and CalciMedica Inc (CALC) among others .
Insider Ownership Summary of Deerfield Management Company, L.p. (series C)
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCR | Oncorus Inc | 2020-10-01 | director & 10 percent owner & other: *Possible Member of 10% Group |
| LRMR | Larimar Therapeutics Inc | 2016-02-09 | 10 percent owner & other: Possible Member of 10% Group |
| CALC | CalciMedica Inc | 2020-09-24 | 10 percent owner & other: Possible Member of 10% Group |
| AFIB | Acutus Medical Inc | 2020-08-05 | director & 10 percent owner & other: Director by Deputization |
| ANNX | Annexon Inc | 2020-07-23 | 10 percent owner & other: Possible Member of 10% Group |
| DFHTU | Deerfield Healthcare Technology Acquisitions Corp | 2020-07-21 | director & 10 percent owner & other: Director by Deputization |
| NKTX | Nkarta Inc | 2020-07-09 | 10 percent owner & other: Possible Member of 10% Group |
| GBIO | Generation Bio Co | 2020-06-11 | 10 percent owner & other: Possible Member of 10% Group |
| LUMO | Lumos Pharma Inc | 2020-03-18 | 10 percent owner & other: Possible Member of 10% Group |
| DFPHU | DFP Healthcare Acquisitions Corp | 2020-03-13 | director & 10 percent owner & other: Director by Deputization |
| RVMD | Revolution Medicines Inc | 2020-02-12 | 10 percent owner & other: Possible Member of 10% Group |
| SDGR | Schrodinger Inc | 2020-02-05 | 10 percent owner & other: Possible Member of 10% Group |
| BDTX | Black Diamond Therapeutics Inc | 2020-01-29 | 10 percent owner & other: Possible Member of 10% Group |
| FIXX | Homology Medicines Inc | 2018-03-27 | 10 percent owner & other: *Director by Deputization |
| DFBHU | AdaptHealth Corp | 2019-11-08 | director & 10 percent owner & other: * Director by Deputization |
| CABA | Cabaletta Bio Inc | 2019-10-24 | 10 percent owner & other: Possible Member of 10% Group |
| FREQ | Frequency Therapeutics Inc | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
| MIRM | Mirum Pharmaceuticals Inc | 2019-07-17 | 10 percent owner & other: Possible Member of 10% Group |
| ACRS | Aclaris Therapeutics Inc | 2018-10-22 | 10 percent owner & other: Possible Member of 10% Group |
| SWAV | Shockwave Medical Inc | 2019-03-06 | 10 percent owner & other: Possible Member of 10% Group |
| XERS | Xeris Biopharma Holdings Inc | 2019-02-08 | 10 percent owner & other: Possible Member of 10% Group |
| ARVN | Arvinas Inc | 2018-09-26 | 10 percent owner & other: Possible Member of 10% Group |
| AERI | Aerie Pharmaceuticals Inc | 2018-07-23 | 10 percent owner & other: Possible Member of 10% Group |
| CNST | Constellation Pharmaceuticals Inc | 2018-07-23 | 10 percent owner & other: Possible member of 10% group |
| AVDL | Avadel Pharmaceuticals PLC | 2018-04-30 | 10 percent owner & other: *Possible member of 10% group |
| TARA | Protara Therapeutics Inc | 2014-10-21 | 10 percent owner & other: Possible Member of 10% Group |
| KNSA | Kiniksa Pharmaceuticals Ltd | 2018-05-23 | 10 percent owner & other: *Possible member of 10% group |
| MNKKQ | Mallinckrodt PLC | 2018-05-08 | 10 percent owner & other: *Possible member of 10% group |
| CBIO | Catalyst Biosciences Inc | 2018-02-15 | 10 percent owner & other: Possible Member of 10% Group |
| RYTM | Rhythm Pharmaceuticals Inc | 2017-10-04 | 10 percent owner & other: Possible Member of 10% Group |
| SCTL | Societal CDMO Inc | 2016-12-16 | 10 percent owner & other: Possible Member of 10% Group |
| EHTH | eHealth Inc | 2015-03-06 | 10 percent owner & other: Possible Member of 10% Group |
| CASM | CAS Medical Systems Inc | 2017-01-24 | 10 percent owner & other: Possible Member of 10% Group |
| IVTY | Invuity Inc | 2016-12-12 | 10 percent owner & other: Possible Member of 10% Group |
| VNDA | Vanda Pharmaceuticals Inc | 2014-12-23 | 10 percent owner & other: Possible Member of 10% Group |
| ALPN | Alpine Immune Sciences Inc | 2015-06-16 | 10 percent owner & other: Possible Member of 10% Group |
| BOLD | Audentes Therapeutics Inc | 2016-07-25 | 10 percent owner & other: Possible Member of 10% Group |
| AXGN | Axogen Inc | 2015-02-10 | 10 percent owner & other: Possible Member of 10% Group |
| SYRS | Syros Pharmaceuticals Inc | 2016-06-29 | 10 percent owner & other: Possible Member of 10% Group |
| XNPT | XenoPort Inc | 2016-02-19 | 10 percent owner & other: Possible Member of 10% Group |
| AVXS | AveXis Inc | 2016-02-10 | 10 percent owner & other: Possible Member of 10% Group |
| EDIT | Editas Medicine Inc | 2016-02-02 | 10 percent owner & other: Possible Member of 10% Group |
| STRM | Streamline Health Solutions Inc | 2015-07-10 | 10 percent owner & other: Possible Member of 10% Group |
| ALIM | Alimera Sciences Inc | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| CTMX | CytomX Therapeutics Inc | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| ATRS | Antares Pharma Inc | 2015-05-11 | 10 percent owner & other: Possible Member of 10% Group |
| RGNX | Regenxbio Inc | 2015-09-16 | 10 percent owner & other: Possible Member of 10% Group |
| NEOS | Neos Therapeutics Inc | 2015-07-28 | 10 percent owner & other: Possible Member of 10% Group |
| LIFE | aTyr Pharma Inc | 2015-05-06 | 10 percent owner & other: Possible Member of 10% Group |
| STDY | SteadyMed Ltd | 2015-03-25 | 10 percent owner & other: Possible Member of 10% Group |
| NVTAQ | Invitae Corp | 2015-02-11 | 10 percent owner & other: Possible Member of 10% Group |
| DRNA | Dicerna Pharmaceuticals Inc | 2014-11-21 | 10 percent owner & other: Possible Member of 10% Group |
| LOXO | Loxo Oncology Inc | 2014-08-06 | 10 percent owner & other: Possible Members of 10% Group |
| ADVM | Adverum Biotechnologies Inc | 2014-08-05 | 10 percent owner & other: Possible Members of 10% Group |
| TRIV | TriVascular Technologies Inc | 2014-04-22 | 10 percent owner & other: Possible Members of 10% Group |
| NXTM | NxStage Medical Inc | 2012-12-04 | 10 percent owner & other: Possible Member of 10% Group |
| RIGL | Rigel Pharmaceuticals Inc | 2010-11-03 | 10 percent owner & other: Possible Members of 10% Group |
| MDCO | The Medicines Co | 2011-04-04 | 10 percent owner & other: Possible Members of 10% Group |
| NURO | NeuroMetrix Inc | 2008-10-27 | 10 percent owner |
| FCSC | Fibrocell Science Inc | 2010-08-16 | 10 percent owner & other: Possible Members of 10% Group |
| NGSX | NeurogesX Inc | 2009-07-13 | 10 percent owner |
| CYCC | Cyclacel Pharmaceuticals Inc | 2008-03-11 | 10 percent owner |
| DVAX | Dynavax Technologies Corp | 2006-01-31 | 10 percent owner & other: Possible Members of 10% Group |
| VIAP | VIA Pharmaceuticals Inc | 2007-11-05 | 10 percent owner & other: Possible Member of 10% Group |
| ARNA | Arena Pharmaceuticals Inc | 2007-10-19 | 10 percent owner |
| EWTX | Edgewise Therapeutics Inc | 2021-03-25 | 10 percent owner & other: Possible Member of 10% Group |
| AHCO | AdaptHealth Corp | 2018-02-15 | director & 10 percent owner & other: Director by Deputization |
| HOWL | Werewolf Therapeutics Inc | 2021-04-29 | 10 percent owner & other: Possible Member of 10% Group |
| TOI | The Oncology Institute Inc | 2020-03-10 | director & 10 percent owner & other: *Director by Deputization |
| CMAX | CareMax Inc | 2020-07-16 | director & 10 percent owner & other: *Director by Deputization |
| TERN | Terns Pharmaceuticals Inc | 2020-02-04 | 10 percent owner & other: Possible Member of 10% Group |
| IGNYU | Ignyte Acquisition Corp | 2020-02-01 | 10 percent owner & other: Possible Member of 10% Group |
| PEPG | PepGen Inc | 2022-05-05 | 10 percent owner & other: *Possible Member of 10% Group |
| XLO | Xilio Therapeutics Inc | 2021-10-21 | 10 percent owner & other: *Possible Member of 10% Group |
| OMIC | Singular Genomics Systems Inc | 2021-05-26 | 10 percent owner & other: *Possible Member of 10% Group |
| NUVL | Nuvalent Inc | 2021-07-28 | director & 10 percent owner & other: Director by Deputization |
| DALS | DA32 Life Science Tech Acquisition Corp | 2021-07-30 | director & 10 percent owner & other: Director by deputization |
| IGNY | Ignyte Acquisition Corp | 2020-02-01 | 10 percent owner & other: Possible Member of 10% Group |
| MCKPF | Mallinckrodt PLC | 2018-05-08 | 10 percent owner & other: *Possible member of 10% group |
| SBTX | Silverback Therapeutics Inc | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
| PKBO | Peak Bio Inc | 2020-02-01 | 10 percent owner & other: Possible Member of 10% Group |
| FLAC | Frazier Lifesciences Acquisition Corp | 2022-11-08 | 10 percent owner & other: Possible Member of 10% Group |
| SPRY | ARS Pharmaceuticals Inc | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
| FLACU | Frazier Lifesciences Acquisition Corp | 2022-11-08 | 10 percent owner & other: Possible Member of 10% Group |
| KRRO | Korro Bio Inc | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
Deerfield Management Company, L.p. (series C) Latest Holdings Summary
Deerfield Management Company, L.p. (series C) currently owns a total of 2 stocks. Among these stocks, Deerfield Management Company, L.p. (series C) owns 3,850,000 shares of DA32 Life Science Tech Acquisition Corp (DALS) as of July 30, 2021, with a value of $40 Million and a weighting of 72.88%. Deerfield Management Company, L.p. (series C) also owns 3,264,588 shares of eHealth Inc (EHTH) as of March 6, 2015, with a value of $15 Million and a weighting of 27.12%.
Latest Holdings of Deerfield Management Company, L.p. (series C)
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DALS | DA32 Life Science Tech Acquisition Corp | 2021-07-30 | 3,850,000 | 10.32 | 39,732,000 |
| EHTH | eHealth Inc | 2015-03-06 | 3,264,588 | 4.53 | 14,788,584 |
Holding Weightings of Deerfield Management Company, L.p. (series C)
Deerfield Management Company, L.p. (series C) Form 4 Trading Tracker
According to the SEC Form 4 filings, Deerfield Management Company, L.p. (series C) has made a total of 1 transactions in DA32 Life Science Tech Acquisition Corp (DALS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DA32 Life Science Tech Acquisition Corp is the acquisition of 1,600,000 shares on July 30, 2021, which cost Deerfield Management Company, L.p. (series C) around $16 Million.
According to the SEC Form 4 filings, Deerfield Management Company, L.p. (series C) has made a total of 0 transactions in eHealth Inc (EHTH) over the past 5 years. The most-recent trade in eHealth Inc is the sale of 1,342,573 shares on March 6, 2015, which brought Deerfield Management Company, L.p. (series C) around $13 Million.
Insider Trading History of Deerfield Management Company, L.p. (series C)
- 1
Deerfield Management Company, L.p. (series C) Trading Performance
GuruFocus tracks the stock performance after each of Deerfield Management Company, L.p. (series C)'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deerfield Management Company, L.p. (series C) is -2%. GuruFocus also compares Deerfield Management Company, L.p. (series C)'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Deerfield Management Company, L.p. (series C) within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deerfield Management Company, L.p. (series C)'s insider trading performs compared to the benchmark.
Performance of Deerfield Management Company, L.p. (series C)
Average Return
-2.8%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.4 | -2 | -4.1 | -2.8 | 1.59 | |
| Relative Return to S&P 500(%) | -5.44 | -6.78 | -4.93 | 3.23 | -0.52 |
Deerfield Management Company, L.p. (series C) Ownership Network
Ownership Network List of Deerfield Management Company, L.p. (series C)
Ownership Network Relation of Deerfield Management Company, L.p. (series C)
Deerfield Management Company, L.p. (series C) Owned Company Details
What does Oncorus Inc do?
Who are the key executives at Oncorus Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: *Possible Member of 10% Group of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .
Oncorus Inc (ONCR) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Oncorus Inc (ONCR). Other recent insider transactions involving Oncorus Inc (ONCR) include a net sale of 551,663 shares made by James E Flynn ,
In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.
Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncorus Inc Insider Transactions
- Download to Excel(.xls)
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Carole Ben-maimon , and a net purchase of 5,000 shares made by Gopi Shankar .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does CalciMedica Inc do?
Who are the key executives at CalciMedica Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp , and director & 10 percent owner Fred A Middleton .
CalciMedica Inc (CALC) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 65,404 shares made by Eric W Roberts , a net purchase of 20,768 shares made by A. Rachel Leheny , and a net purchase of 691,098 shares made by Fred A Middleton .
In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,505,415 shares were bought by its insiders, resulting in a net purchase of 1,505,415 shares.
CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CalciMedica Inc Insider Transactions
- Download to Excel(.xls)
What does Acutus Medical Inc do?
Who are the key executives at Acutus Medical Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .
Acutus Medical Inc (AFIB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acutus Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Annexon Inc do?
Who are the key executives at Annexon Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Financial Officer Jennifer Lew , EVP & Chief Innovation Officer Ted Yednock , and EVP & Chief Business Officer Michael Overdorf .
Annexon Inc (ANNX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 47,471 shares made by Ted Yednock , a net sale of 7,367 shares made by Jennifer Lew , and a net sale of 5,923 shares made by Michael Overdorf .
In summary, during the past 3 months, insiders sold 17,898 shares of Annexon Inc (ANNX) in total and bought 3,200 shares, with a net sale of 14,698 shares. During the past 18 months, 73,114 shares of Annexon Inc (ANNX) were sold and 3,300,258 shares were bought by its insiders, resulting in a net purchase of 3,227,144 shares.
Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Annexon Inc Insider Transactions
- Download to Excel(.xls)
What does Deerfield Healthcare Technology Acquisitions Corp do?
Who are the key executives at Deerfield Healthcare Technology Acquisitions Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of Deerfield Healthcare Technology Acquisitions Corp. Other key executives at Deerfield Healthcare Technology Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. , and director & 10 percent owner & other: Director by Deputization James E Flynn .
Deerfield Healthcare Technology Acquisitions Corp (DFHTU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Deerfield Healthcare Technology Acquisitions Corp (DFHTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deerfield Healthcare Technology Acquisitions Corp Insider Transactions
- Download to Excel(.xls)
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Nkarta Inc. Other key executives at Nkarta Inc include 10 percent owner Ra Capital Healthcare Fund Lp , Chief Scientific Officer James Trager , and Chief Medical Officer David Shook .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .
In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
- Download to Excel(.xls)
What does Generation Bio Co do?
Who are the key executives at Generation Bio Co?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Generation Bio Co. Other key executives at Generation Bio Co include CHIEF OPERATING OFFICER Antoinette Paone , CHIEF LEGAL OFFICER Yalonda Howze , and CHIEF STRATEGY OFFICER Phillip Samayoa .
Generation Bio Co (GBIO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net sale of 10,590 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .
In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,455 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 539,000 shares.
Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Generation Bio Co Insider Transactions
- Download to Excel(.xls)
What does Lumos Pharma Inc do?
Who are the key executives at Lumos Pharma Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .
Lumos Pharma Inc (LUMO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lumos Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does DFP Healthcare Acquisitions Corp do?
Who are the key executives at DFP Healthcare Acquisitions Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of DFP Healthcare Acquisitions Corp. Other key executives at DFP Healthcare Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. , and director & 10 percent owner & other: Director by Deputization James E Flynn .
DFP Healthcare Acquisitions Corp (DFPHU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DFP Healthcare Acquisitions Corp (DFPHU)'s detailed insider trading history can be found in Insider Trading Tracker table.
DFP Healthcare Acquisitions Corp Insider Transactions
- Download to Excel(.xls)
What does Revolution Medicines Inc do?
Who are the key executives at Revolution Medicines Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include director & See Remarks Mark A Goldsmith , General Counsel Jeff Cislini , and See Remarks Margaret A Horn .
Revolution Medicines Inc (RVMD) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 127,178 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 12,934 shares made by Jeff Cislini .
In summary, during the past 3 months, insiders sold 58,164 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 58,164 shares. During the past 18 months, 362,724 shares of Revolution Medicines Inc (RVMD) were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 287,276 shares.
Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revolution Medicines Inc Insider Transactions
- Download to Excel(.xls)
What does Schrodinger Inc do?
Who are the key executives at Schrodinger Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Schrodinger Inc. Other key executives at Schrodinger Inc include EVP & CFO Geoffrey Craig Porges , See Remarks Robert Lorne Abel , and See Remarks Yvonne Tran .
Schrodinger Inc (SDGR) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Schrodinger Inc (SDGR). Other recent insider transactions involving Schrodinger Inc (SDGR) include a net sale of 60,758 shares made by Yvonne Tran , a net sale of 20,901 shares made by Kenneth Patrick Lorton , and a net sale of 66,886 shares made by Ramy Farid .
In summary, during the past 3 months, insiders sold 6,966 shares of Schrodinger Inc (SDGR) in total and bought 0 shares, with a net sale of 6,966 shares. During the past 18 months, 168,702 shares of Schrodinger Inc (SDGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,702 shares.
Schrodinger Inc (SDGR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Schrodinger Inc Insider Transactions
- Download to Excel(.xls)
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , director & 10 percent owner Ali Behbahani , and director & See Remarks David M. Epstein .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,604,453 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,596,666 shares were bought by its insiders, resulting in a net purchase of 5,571,666 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Director by Deputization of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
- Download to Excel(.xls)
What does AdaptHealth Corp do?
Who are the key executives at AdaptHealth Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: * Director by Deputization of AdaptHealth Corp. Other key executives at AdaptHealth Corp include Chief Accounting Officer Frank Mullen , 10 percent owner Oep Vii Project A-i Co-investment Partners, L.p. , and 10 percent owner Oep Vii Project A Co-investment Partners, L.p. .
AdaptHealth Corp (DFBHU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AdaptHealth Corp (DFBHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AdaptHealth Corp (DFBHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AdaptHealth Corp (DFBHU)'s detailed insider trading history can be found in Insider Trading Tracker table.
AdaptHealth Corp Insider Transactions
- Download to Excel(.xls)
What does Cabaletta Bio Inc do?
Who are the key executives at Cabaletta Bio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .
Cabaletta Bio Inc (CABA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,
In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.
Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabaletta Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Frequency Therapeutics Inc do?
Who are the key executives at Frequency Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .
Frequency Therapeutics Inc (FREQ) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .
In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.
Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frequency Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mirum Pharmaceuticals Inc do?
Who are the key executives at Mirum Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include Chief Financial Officer Eric Bjerkholt , Chief Operating Officer Peter Radovich , and SVP & Global Controller Jolanda Howe .
Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .
In summary, during the past 3 months, insiders sold 14,902 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 4,000 shares, with a net sale of 10,902 shares. During the past 18 months, 393,444 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 175,963 shares were bought by its insiders, resulting in a net sale of 217,481 shares.
Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirum Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,164 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 206,169 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Shockwave Medical Inc do?
Who are the key executives at Shockwave Medical Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Shockwave Medical Inc. Other key executives at Shockwave Medical Inc include Chief Commercial Officer Isaac Zacharias , VP & Finance Trinh Phung , and director & President & CEO Douglas Evan Godshall .
Shockwave Medical Inc (SWAV) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Shockwave Medical Inc (SWAV). Other recent insider transactions involving Shockwave Medical Inc (SWAV) include a net sale of 72,000 shares made by Isaac Zacharias , a net sale of 49,000 shares made by Frank T Watkins , and a net sale of 21,113 shares made by Dan Puckett .
In summary, during the past 3 months, insiders sold 93,042 shares of Shockwave Medical Inc (SWAV) in total and bought 0 shares, with a net sale of 93,042 shares. During the past 18 months, 312,716 shares of Shockwave Medical Inc (SWAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 312,716 shares.
Shockwave Medical Inc (SWAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shockwave Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 30,000 shares made by Paul R Edick , a net purchase of 11,000 shares made by John P. Schmid , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 4,500 shares, with a net purchase of 4,500 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 110,579 shares were bought by its insiders, resulting in a net purchase of 110,579 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Arvinas Inc. Other key executives at Arvinas Inc include Chief Medical Officer Ronald Peck , Chief Financial Officer Sean A Cassidy , and director & President and CEO John G Houston .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 11,074 shares made by John G Houston , a net sale of 3,447 shares made by Sean A Cassidy , and a net sale of 3,023 shares made by Ronald Peck .
In summary, during the past 3 months, insiders sold 10,298 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 10,298 shares. During the past 18 months, 20,296 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,296 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
- Download to Excel(.xls)
What does Aerie Pharmaceuticals Inc do?
Who are the key executives at Aerie Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .
Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerie Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Constellation Pharmaceuticals Inc do?
Who are the key executives at Constellation Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible member of 10% group of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .
Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Constellation Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
- Download to Excel(.xls)
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include Chief Financial Officer Patrick Fabbio , 10 percent owner Opaleye Management Inc. , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 15,473 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,473 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Kiniksa Pharmaceuticals Ltd do?
Who are the key executives at Kiniksa Pharmaceuticals Ltd?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .
Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.
Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals Ltd Insider Transactions
- Download to Excel(.xls)
What does Mallinckrodt PLC do?
Who are the key executives at Mallinckrodt PLC?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include director & President and CEO Sigurdur O Olafsson , EVP & Chief Sci. Ofcr Steven J. Romano , and 10 percent owner Fyi S.a R.l. .
Mallinckrodt PLC (MNKKQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mallinckrodt PLC Insider Transactions
- Download to Excel(.xls)
What does Catalyst Biosciences Inc do?
Who are the key executives at Catalyst Biosciences Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .
Catalyst Biosciences Inc (CBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , Chief Technical Officer Joseph Shulman , and EVP & Head of North America Jennifer Chien .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .
In summary, during the past 3 months, insiders sold 252,926 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 252,926 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Societal CDMO Inc do?
Who are the key executives at Societal CDMO Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Societal CDMO Inc. Other key executives at Societal CDMO Inc include director & Chief Executive Officer Enloe J David Jr , director & 10 percent owner Mathew Paul Arens , and 10 percent owner Awm Investment Company, Inc. .
Societal CDMO Inc (SCTL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Societal CDMO Inc (SCTL). Other recent insider transactions involving Societal CDMO Inc (SCTL) include a net sale of 230,000 shares made by Awm Investment Company, Inc. , a net purchase of 125,660 shares made by Enloe J David Jr , and a net purchase of 6,250,000 shares made by Mathew Paul Arens .
In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc (SCTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 370,000 shares of Societal CDMO Inc (SCTL) were sold and 6,792,882 shares were bought by its insiders, resulting in a net purchase of 6,422,882 shares.
Societal CDMO Inc (SCTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Societal CDMO Inc Insider Transactions
- Download to Excel(.xls)
What does eHealth Inc do?
Who are the key executives at eHealth Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of eHealth Inc. Other key executives at eHealth Inc include SVP & General Counsel & Secr. Gavin G. Galimi , director & Chief Executive Officer Soistman Francis S Jr , and SVP & Chief Financial Officer John J Stelben .
eHealth Inc (EHTH) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in eHealth Inc (EHTH). Other recent insider transactions involving eHealth Inc (EHTH) include a net purchase of 22,932 shares made by Dale B Wolf , a net purchase of 7,500 shares made by Gavin G. Galimi , and a net purchase of 80,000 shares made by Soistman Francis S Jr .
In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc (EHTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,000 shares of eHealth Inc (EHTH) were sold and 115,432 shares were bought by its insiders, resulting in a net purchase of 110,432 shares.
eHealth Inc (EHTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
eHealth Inc Insider Transactions
- Download to Excel(.xls)
What does CAS Medical Systems Inc do?
Who are the key executives at CAS Medical Systems Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of CAS Medical Systems Inc. Other key executives at CAS Medical Systems Inc include director & President and CEO Thomas M Patton , director & 10 percent owner James E Thomas , and 10 percent owner Thomas, Mcnerney & Partners Ii L.p. .
CAS Medical Systems Inc (CASM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CAS Medical Systems Inc (CASM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CAS Medical Systems Inc (CASM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CAS Medical Systems Inc (CASM)'s detailed insider trading history can be found in Insider Trading Tracker table.
CAS Medical Systems Inc Insider Transactions
- Download to Excel(.xls)
What does Invuity Inc do?
Who are the key executives at Invuity Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Invuity Inc. Other key executives at Invuity Inc include Chief Financial Officer James H Mackaness , 10 percent owner & other: Possible Member of 10% Group James E Flynn , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
Invuity Inc (IVTY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invuity Inc Insider Transactions
- Download to Excel(.xls)
What does Vanda Pharmaceuticals Inc do?
Who are the key executives at Vanda Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include director & Chief Executive Officer Mihael Hristos Polymeropoulos , SVP & General Counsel Timothy Williams , and SVP & Business Development Gunther Birznieks .
Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .
In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.
Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vanda Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Peter A. Thompson .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,510 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,510 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Audentes Therapeutics Inc do?
Who are the key executives at Audentes Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Audentes Therapeutics Inc. Other key executives at Audentes Therapeutics Inc include President and COO Natalie C. Holles , SVP & Chief Medical Officer Edward R. Conner , and Executive Vice President & CFO Thomas P Soloway .
Audentes Therapeutics Inc (BOLD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Audentes Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Axogen Inc do?
Who are the key executives at Axogen Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Axogen Inc. Other key executives at Axogen Inc include Chief R&D Officer Angelo Scopelianos , director & CEO Karen L. Zaderej , and VP & Clinical&Translational Sc Erick Wayne Devinney .
Axogen Inc (AXGN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Axogen Inc (AXGN). Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 100,448 shares made by Gregory Gene Freitag , a net sale of 128,948 shares made by Peter J Mariani , and a net sale of 42,343 shares made by Michael Patrick Donovan .
In summary, during the past 3 months, insiders sold 118,082 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 118,082 shares. During the past 18 months, 322,478 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 292,478 shares.
Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axogen Inc Insider Transactions
- Download to Excel(.xls)
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Medical Officer David Roth , Chief Scientific Officer Eric R Olson , and Chief Financial Officer Jason Haas .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .
In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XenoPort Inc do?
Who are the key executives at XenoPort Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. , and 10 percent owner & other: Possible Member of 10% Group Deerfield Partners, L.p. .
XenoPort Inc (XNPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
XenoPort Inc Insider Transactions
- Download to Excel(.xls)
What does AveXis Inc do?
Who are the key executives at AveXis Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of AveXis Inc. Other key executives at AveXis Inc include director & President & CEO Sean P. Nolan , 10 percent owner Ag Novartis , and Chief Financial Officer Phillip B. Donenberg .
AveXis Inc (AVXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
AveXis Inc Insider Transactions
- Download to Excel(.xls)
What does Editas Medicine Inc do?
Who are the key executives at Editas Medicine Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Editas Medicine Inc. Other key executives at Editas Medicine Inc include director & CEO Gilmore Neil O'neill , SVP & CHIEF MEDICAL OFFICER Baisong Mei , and EVP & Chief Business Officer Bruce Eaton .
Editas Medicine Inc (EDIT) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 6,936 shares made by Bruce Eaton , a net sale of 7,365 shares made by Michelle Robertson , and a net sale of 84,310 shares made by Gilmore Neil O'neill .
In summary, during the past 3 months, insiders sold 98,151 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 98,151 shares. During the past 18 months, 126,045 shares of Editas Medicine Inc (EDIT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 126,045 shares.
Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Editas Medicine Inc Insider Transactions
- Download to Excel(.xls)
What does Streamline Health Solutions Inc do?
Who are the key executives at Streamline Health Solutions Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Streamline Health Solutions Inc. Other key executives at Streamline Health Solutions Inc include Interim CFO Reeves Bryant J Iii , President Benjamin Louis Stilwill , and Chief People Officer Wendy L Lucio .
Streamline Health Solutions Inc (STRM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Streamline Health Solutions Inc (STRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Streamline Health Solutions Inc (STRM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Streamline Health Solutions Inc (STRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Streamline Health Solutions Inc Insider Transactions
- Download to Excel(.xls)
What does Alimera Sciences Inc do?
Who are the key executives at Alimera Sciences Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .
Alimera Sciences Inc (ALIM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.
Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alimera Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and See Remarks Peter J Graham .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Regenxbio Inc. Other key executives at Regenxbio Inc include director & See Remarks Kenneth T. Mills , Chief Medical Officer Steve Pakola , and See Remarks Vittal Vasista .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 135,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .
In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
- Download to Excel(.xls)
What does Neos Therapeutics Inc do?
Who are the key executives at Neos Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , Chief Financial Officer Richard I Eisenstadt , and SVP & General Counsel John M Limongelli .
Neos Therapeutics Inc (NEOS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .
aTyr Pharma Inc (LIFE) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in aTyr Pharma Inc (LIFE). Other recent insider transactions involving aTyr Pharma Inc (LIFE) include a net purchase of 55,000 shares made by Sanjay Shukla , a net sale of 3,156 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .
In summary, during the past 3 months, insiders sold 1,590 shares of aTyr Pharma Inc (LIFE) in total and bought 0 shares, with a net sale of 1,590 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc (LIFE) were sold and 255,000 shares were bought by its insiders, resulting in a net purchase of 251,844 shares.
aTyr Pharma Inc (LIFE)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does SteadyMed Ltd do?
Who are the key executives at SteadyMed Ltd?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of SteadyMed Ltd. Other key executives at SteadyMed Ltd include 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp Vi Llc , and director & 10 percent owner Brian Jay Stark .
SteadyMed Ltd (STDY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.
SteadyMed Ltd Insider Transactions
- Download to Excel(.xls)
What does Invitae Corp do?
Who are the key executives at Invitae Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Invitae Corp. Other key executives at Invitae Corp include Chief Financial Officer Ana J. Schrank , Chief Commercial Officer Robert M. Guigley , and See Remarks Robert Iv Dickey .
Invitae Corp (NVTAQ) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 92,717 shares made by Kenneth D. Knight , a net sale of 89,529 shares made by Yafei Wen , and a net sale of 36,187 shares made by Robert L Nussbaum .
In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 332,151 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,151 shares.
Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invitae Corp Insider Transactions
- Download to Excel(.xls)
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Loxo Oncology Inc do?
Who are the key executives at Loxo Oncology Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .
Loxo Oncology Inc (LOXO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Loxo Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 23,000 shares, with a net purchase of 23,000 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
- Download to Excel(.xls)
What does TriVascular Technologies Inc do?
Who are the key executives at TriVascular Technologies Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .
TriVascular Technologies Inc (TRIV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
TriVascular Technologies Inc Insider Transactions
- Download to Excel(.xls)
What does NxStage Medical Inc do?
Who are the key executives at NxStage Medical Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of NxStage Medical Inc. Other key executives at NxStage Medical Inc include director & Chief Executive Officer Jeffrey H Burbank , Chief Accounting Officer Kevin Hershberger , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
NxStage Medical Inc (NXTM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc (NXTM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc (NXTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NxStage Medical Inc (NXTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NxStage Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 18,017 shares made by Dean L Schorno .
In summary, during the past 3 months, insiders sold 80,041 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 80,041 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does The Medicines Co do?
Who are the key executives at The Medicines Co?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of The Medicines Co. Other key executives at The Medicines Co include Chief Development Officer Peter Wijngaard , EVP & Chief Corp. Dev. Officer Christopher T Cox , and director & Executive Chairman Fredric N Eshelman .
The Medicines Co (MDCO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of The Medicines Co (MDCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of The Medicines Co (MDCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
The Medicines Co (MDCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
The Medicines Co Insider Transactions
- Download to Excel(.xls)
What does NeuroMetrix Inc do?
Who are the key executives at NeuroMetrix Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of NeuroMetrix Inc. Other key executives at NeuroMetrix Inc include Chief Financial Officer Thomas T Higgins , other: See Explanation in Footnotes Topline Capital Management, Llc , and 10 percent owner Topline Capital Partners, Lp .
NeuroMetrix Inc (NURO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NeuroMetrix Inc (NURO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeuroMetrix Inc (NURO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NeuroMetrix Inc (NURO)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuroMetrix Inc Insider Transactions
- Download to Excel(.xls)
What does Fibrocell Science Inc do?
Who are the key executives at Fibrocell Science Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Fibrocell Science Inc. Other key executives at Fibrocell Science Inc include 10 percent owner Randal J Kirk , 10 percent owner Intrexon Corp , and director & Chairman and CEO David Pernock .
Fibrocell Science Inc (FCSC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Fibrocell Science Inc (FCSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fibrocell Science Inc (FCSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Fibrocell Science Inc (FCSC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fibrocell Science Inc Insider Transactions
- Download to Excel(.xls)
What does NeurogesX Inc do?
Who are the key executives at NeurogesX Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of NeurogesX Inc. Other key executives at NeurogesX Inc include President and CEO Ron Martell , Exec. V.P. & COO & CFO Stephen F Ghiglieri , and director & 10 percent owner Robert Nelsen .
NeurogesX Inc (NGSX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeurogesX Inc Insider Transactions
- Download to Excel(.xls)
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Dynavax Technologies Corp do?
Who are the key executives at Dynavax Technologies Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .
Dynavax Technologies Corp (DVAX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 238,719 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 4,500,000 shares made by Hack Andrew A. F. .
In summary, during the past 3 months, insiders sold 20,526 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 20,526 shares. During the past 18 months, 4,836,004 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,836,004 shares.
Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dynavax Technologies Corp Insider Transactions
- Download to Excel(.xls)
What does VIA Pharmaceuticals Inc do?
Who are the key executives at VIA Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of VIA Pharmaceuticals Inc. Other key executives at VIA Pharmaceuticals Inc include 10 percent owner Bay City Capital Llc , 10 percent owner Bay City Capital Fund Iv Co Invesment Fund Lp , and 10 percent owner Bay City Capital Management Iv Llc .
VIA Pharmaceuticals Inc (VIAP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of VIA Pharmaceuticals Inc (VIAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIA Pharmaceuticals Inc (VIAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
VIA Pharmaceuticals Inc (VIAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
VIA Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Arena Pharmaceuticals Inc do?
Who are the key executives at Arena Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , EVP & Chief Commercial Officer Robert Lisicki , and Executive VP and CBO Vincent Aurentz .
Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arena Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Edgewise Therapeutics Inc do?
Who are the key executives at Edgewise Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Edgewise Therapeutics Inc. Other key executives at Edgewise Therapeutics Inc include General Counsel John R Moore , Chief Business Officer Behrad Derakhshan , and director & 10 percent owner Orbimed Advisors Llc .
Edgewise Therapeutics Inc (EWTX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Edgewise Therapeutics Inc (EWTX). Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 40,229 shares made by John R Moore , a net sale of 174,187 shares made by Alan J Russell , and a net sale of 91,336 shares made by R Michael Carruthers .
In summary, during the past 3 months, insiders sold 39,835 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 0 shares, with a net sale of 39,835 shares. During the past 18 months, 323,956 shares of Edgewise Therapeutics Inc (EWTX) were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 595,991 shares.
Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Edgewise Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does AdaptHealth Corp do?
Who are the key executives at AdaptHealth Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of AdaptHealth Corp. Other key executives at AdaptHealth Corp include director & 10 percent owner & other: Director by Deputization James E Flynn , Chief Technology Officer Albert A. Prast , and Chief Financial Officer Jason A Clemens .
AdaptHealth Corp (AHCO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in AdaptHealth Corp (AHCO). Other recent insider transactions involving AdaptHealth Corp (AHCO) include a net sale of 1,280,868 shares made by Everest Hill Group Inc. , a net sale of 350,000 shares made by James E Flynn , and a net sale of 325,627 shares made by Skyknight Aero Holdings, Llc .
In summary, during the past 3 months, insiders sold 350,000 shares of AdaptHealth Corp (AHCO) in total and bought 0 shares, with a net sale of 350,000 shares. During the past 18 months, 2,348,828 shares of AdaptHealth Corp (AHCO) were sold and 720 shares were bought by its insiders, resulting in a net sale of 2,348,108 shares.
AdaptHealth Corp (AHCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AdaptHealth Corp Insider Transactions
- Download to Excel(.xls)
What does Werewolf Therapeutics Inc do?
Who are the key executives at Werewolf Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .
Werewolf Therapeutics Inc (HOWL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net purchase of 1,853,000 shares made by Ra Capital Healthcare Fund Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 1,853,000 shares were bought by its insiders, resulting in a net purchase of 1,853,000 shares.
Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Werewolf Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does The Oncology Institute Inc do?
Who are the key executives at The Oncology Institute Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: *Director by Deputization of The Oncology Institute Inc. Other key executives at The Oncology Institute Inc include 10 percent owner Havencrest Healthcare Partners, L.p. , Chief Financial Officer & other: Principal Financial Officer Mihir Shah , and director & Chief Executive Officer Brad Hively .
The Oncology Institute Inc (TOI) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in The Oncology Institute Inc (TOI). Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net sale of 1,018,687 shares made by Havencrest Healthcare Partners, L.p. , a net sale of 81,718 shares made by Brad Hively , and a net purchase of 73,107 shares made by Matthew P Miller .
In summary, during the past 3 months, insiders sold 8,637 shares of The Oncology Institute Inc (TOI) in total and bought 0 shares, with a net sale of 8,637 shares. During the past 18 months, 1,121,132 shares of The Oncology Institute Inc (TOI) were sold and 223,684 shares were bought by its insiders, resulting in a net sale of 897,448 shares.
The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.
The Oncology Institute Inc Insider Transactions
- Download to Excel(.xls)
What does CareMax Inc do?
Who are the key executives at CareMax Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: *Director by Deputization of CareMax Inc. Other key executives at CareMax Inc include director & 10 percent owner De La Torre Ralph , EVP and COO Solo Alberto De , and director & President and CEO De Solo Carlos A. .
CareMax Inc (CMAX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in CareMax Inc (CMAX). Other recent insider transactions involving CareMax Inc (CMAX) include a net purchase of 10,000 shares made by Bryan Cho ,
In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc (CMAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc (CMAX) were sold and 333 shares were bought by its insiders, resulting in a net purchase of 333 shares.
CareMax Inc (CMAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CareMax Inc Insider Transactions
- Download to Excel(.xls)
What does Terns Pharmaceuticals Inc do?
Who are the key executives at Terns Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Terns Pharmaceuticals Inc. Other key executives at Terns Pharmaceuticals Inc include 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Financial Officer Mark J. Vignola , and COO and General Counsel Seokho Bryan Yoon .
Terns Pharmaceuticals Inc (TERN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 10,743 shares made by Mark J. Vignola , a net purchase of 10,743 shares made by Seokho Bryan Yoon , and a net purchase of 337,957 shares made by Vivo Opportunity Fund Holdings, L.p. .
In summary, during the past 3 months, insiders sold 420,663 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 0 shares, with a net sale of 420,663 shares. During the past 18 months, 1,920,663 shares of Terns Pharmaceuticals Inc (TERN) were sold and 1,816,702 shares were bought by its insiders, resulting in a net sale of 103,961 shares.
Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Terns Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Ignyte Acquisition Corp do?
Who are the key executives at Ignyte Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .
Ignyte Acquisition Corp (IGNYU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ignyte Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does PepGen Inc do?
Who are the key executives at PepGen Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible Member of 10% Group of PepGen Inc. Other key executives at PepGen Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , director & President and CEO James G Mcarthur , and See Remarks Jaya Goyal .
PepGen Inc (PEPG) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 29,556 shares made by James G Mcarthur , a net sale of 6,392 shares made by Jaya Goyal , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of PepGen Inc (PEPG) in total and bought 2,557,593 shares, with a net purchase of 2,557,593 shares. During the past 18 months, 37,642 shares of PepGen Inc (PEPG) were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,521,645 shares.
PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.
PepGen Inc Insider Transactions
- Download to Excel(.xls)
What does Xilio Therapeutics Inc do?
Who are the key executives at Xilio Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible Member of 10% Group of Xilio Therapeutics Inc. Other key executives at Xilio Therapeutics Inc include 10 percent owner Atlas Venture Fund Xi, L.p. , Chief Medical Officer Katarina Luptakova , and Chief Operating Officer Christopher James Frankenfield .
Xilio Therapeutics Inc (XLO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .
In summary, during the past 3 months, insiders sold 1,000 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 484,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.
Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xilio Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Singular Genomics Systems Inc do?
Who are the key executives at Singular Genomics Systems Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible Member of 10% Group of Singular Genomics Systems Inc. Other key executives at Singular Genomics Systems Inc include director & 10 percent owner & Chief Executive Officer Andrew Spaventa , Chief Scientific Officer Eli N. Glezer , and Chief Operating Officer Jyotsna Ghai .
Singular Genomics Systems Inc (OMIC) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Singular Genomics Systems Inc (OMIC). Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 420,000 shares made by Eli N. Glezer , a net sale of 631,648 shares made by Kim P. Kamdar , and a net purchase of 118,468 shares made by Andrew Spaventa .
In summary, during the past 3 months, insiders sold 0 shares of Singular Genomics Systems Inc (OMIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 631,648 shares of Singular Genomics Systems Inc (OMIC) were sold and 538,468 shares were bought by its insiders, resulting in a net sale of 93,180 shares.
Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Singular Genomics Systems Inc Insider Transactions
- Download to Excel(.xls)
What does Nuvalent Inc do?
Who are the key executives at Nuvalent Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of Nuvalent Inc. Other key executives at Nuvalent Inc include Chief Legal Officer Deborah Ann Miller , See Remarks Darlene Noci , and Chief Financial Officer Alexandra Balcom .
Nuvalent Inc (NUVL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Nuvalent Inc (NUVL). Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 136,400 shares made by Darlene Noci , a net sale of 103,546 shares made by Deborah Ann Miller , and a net sale of 579,494 shares made by Matthew Shair .
In summary, during the past 3 months, insiders sold 1,132,833 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 1,132,833 shares. During the past 18 months, 1,801,333 shares of Nuvalent Inc (NUVL) were sold and 799,253 shares were bought by its insiders, resulting in a net sale of 1,002,080 shares.
Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuvalent Inc Insider Transactions
- Download to Excel(.xls)
What does DA32 Life Science Tech Acquisition Corp do?
Who are the key executives at DA32 Life Science Tech Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by deputization of DA32 Life Science Tech Acquisition Corp. Other key executives at DA32 Life Science Tech Acquisition Corp include director & 10 percent owner Keith Crandell , 10 percent owner & other: Director by Deputization Section 32 Fund 3, Lp , and 10 percent owner Arch Venture Fund Xi, L.p. .
DA32 Life Science Tech Acquisition Corp (DALS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DA32 Life Science Tech Acquisition Corp (DALS)'s detailed insider trading history can be found in Insider Trading Tracker table.
DA32 Life Science Tech Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Ignyte Acquisition Corp do?
Who are the key executives at Ignyte Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include 10 percent owner Ignyte Sponsor Llc , director & 10 percent owner & Co-Chief Executive Officer David I. Rosenberg , and director & 10 percent owner & Co-Chief Executive Officer David J. Strupp .
Ignyte Acquisition Corp (IGNY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ignyte Acquisition Corp (IGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ignyte Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Mallinckrodt PLC do?
Who are the key executives at Mallinckrodt PLC?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include 10 percent owner Alta Fundamental Advisers Llc , EVP & Head of Corp Development Jason Daniel Goodson , and director & President and CEO Sigurdur O Olafsson .
Mallinckrodt PLC (MCKPF) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Mallinckrodt PLC (MCKPF). Other recent insider transactions involving Mallinckrodt PLC (MCKPF) include a net purchase of 30,000 shares made by James R Sulat , a net purchase of 5,000 shares made by Paul Bisaro , and a net purchase of 3,000 shares made by Sigurdur O Olafsson .
In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MCKPF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MCKPF) were sold and 40,133 shares were bought by its insiders, resulting in a net purchase of 40,133 shares.
Mallinckrodt PLC (MCKPF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mallinckrodt PLC Insider Transactions
- Download to Excel(.xls)
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: * Director by deputization of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: Director by deputization James E Flynn .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Peak Bio Inc do?
Who are the key executives at Peak Bio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Peak Bio Inc. Other key executives at Peak Bio Inc include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .
Peak Bio Inc (PKBO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Peak Bio Inc (PKBO). Other recent insider transactions involving Peak Bio Inc (PKBO) include a net purchase of 190,250 shares made by Hoyoung Huh ,
In summary, during the past 3 months, insiders sold 0 shares of Peak Bio Inc (PKBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Peak Bio Inc (PKBO) were sold and 190,250 shares were bought by its insiders, resulting in a net purchase of 190,250 shares.
Peak Bio Inc (PKBO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Peak Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. , and 10 percent owner & other: Possible Member of 10% Group Deerfield Partners, L.p. .
Frazier Lifesciences Acquisition Corp (FLAC) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Frazier Lifesciences Acquisition Corp (FLAC). Other recent insider transactions involving Frazier Lifesciences Acquisition Corp (FLAC) include a net purchase of 847,062 shares made by Viking Global Investors Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) were sold and 847,062 shares were bought by its insiders, resulting in a net purchase of 847,062 shares.
Frazier Lifesciences Acquisition Corp (FLAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does ARS Pharmaceuticals Inc do?
Who are the key executives at ARS Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: * Director by deputization of ARS Pharmaceuticals Inc. Other key executives at ARS Pharmaceuticals Inc include 10 percent owner & Chief Medical Officer Sarina Tanimoto , director & 10 percent owner & President and CEO Richard E Lowenthal , and Chief Legal Officer Alexander A Fitzpatrick .
ARS Pharmaceuticals Inc (SPRY) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 543,896 shares made by Laura Shawver , a net sale of 503,260 shares made by Sarina Tanimoto , and a net sale of 503,260 shares made by Richard E Lowenthal .
In summary, during the past 3 months, insiders sold 1,006,520 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 1,401,299 shares, with a net purchase of 394,779 shares. During the past 18 months, 1,550,416 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,945,807 shares were bought by its insiders, resulting in a net purchase of 7,395,391 shares.
ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARS Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. , and 10 percent owner & other: Possible Member of 10% Group Deerfield Partners, L.p. .
Frazier Lifesciences Acquisition Corp (FLACU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLACU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Korro Bio Inc do?
Who are the key executives at Korro Bio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Korro Bio Inc. Other key executives at Korro Bio Inc include 10 percent owner Scott D Sandell , 10 percent owner New Enterprise Associates 17, L.p. , and 10 percent owner Rick Yang .
Korro Bio Inc (KRRO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 2,124 shares made by David L. Lucchino , a net purchase of 17,857 shares made by Florence Anthony A. Jr. , and a net purchase of 17,857 shares made by Carmen Chang .
In summary, during the past 3 months, insiders sold 0 shares of Korro Bio Inc (KRRO) in total and bought 178,570 shares, with a net purchase of 178,570 shares. During the past 18 months, 2,124 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 176,446 shares.
Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Korro Bio Inc Insider Transactions
- Download to Excel(.xls)
Deerfield Management Company, L.p. (series C) Mailing Address
Above is the net worth, insider trading, and ownership report for Deerfield Management Company, L.p. (series C). You might contact Deerfield Management Company, L.p. (series C) via mailing address: 345 Park Avenue South, 12th Floor, New York Ny 10010.
Discussions on Deerfield Management Company, L.p. (series C)
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
